|
Diabetes, Vol 46, Issue 4 583-588, Copyright © 1997 by American Diabetes Association
Glutamate decarboxylase-reactive peripheral blood lymphocytes from patients with IDDM express gut-specific homing receptor alpha4beta7-integrin
J Paronen, P Klemetti, JM Kantele, E Savilahti, J Perheentupa, HK Akerblom and O Vaarala
University of Helsinki, Finland.
Migration of lymphocytes to the pancreas is a prerequisite for insulitis in
IDDM. Mucosal vascular addressin (MAdCAM-1), involved in the recirculation
of lymphocytes to the gut, has been found in the inflamed islets in NOD
mice. In humans, triggers of the gut immune system (e.g., early exposure to
cow's milk proteins in infancy, exposure to enteroviral infections) have
been associated with IDDM. To study the possible link between the gut
immune system and IDDM, we tested the expression of the
alpha4beta7-integrin, a homing receptor for MAdCAM-1, on GAD65-reactive
lymphocytes. Using immunomagnetic cell sorting, we depleted the lymphocytes
with high expression of alpha4beta7-integrin in the peripheral blood
mononuclear cell population from IDDM patients and patients with autoimmune
polyendocrine disease type 1 (APD-I). The depletion led to a marked
decrease (mean 70%) in the cellular response against GAD65 in three of six
IDDM patients and in one subject at high risk for IDDM. A decrease of 37%
in the GAD response was observed after depletion in the case of one APD-I
patient who also had IDDM. Cellular response to tetanus toxoid increased in
the majority of patients as well as in three control subjects studied. We
demonstrated that a remarkable population of islet cell antigen-reactive
lymphocytes express the gut-specific homing receptor, which emphasizes the
role of gut immunity in IDDM. The manipulation of the gut immune system is
therefore proposed as a tool for modulation of the autoimmunity against
pancreatic beta-cells in IDDM.

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
A. Sapone, L. de Magistris, M. Pietzak, M. G. Clemente, A. Tripathi, F. Cucca, R. Lampis, D. Kryszak, M. Carteni, M. Generoso, et al.
Zonulin upregulation is associated with increased gut permeability in subjects with type 1 diabetes and their relatives.
Diabetes,
May 1, 2006;
55(5):
1443 - 1449.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Sblattero, F. Maurano, G. Mazzarella, M. Rossi, S. Auricchio, F. Florian, F. Ziberna, A. Tommasini, T. Not, A. Ventura, et al.
Characterization of the Anti-Tissue Transglutaminase Antibody Response in Nonobese Diabetic Mice
J. Immunol.,
May 1, 2005;
174(9):
5830 - 5836.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Watts, I. Berti, A. Sapone, T. Gerarduzzi, T. Not, R. Zielke, and A. Fasano
Role of the intestinal tight junction modulator zonulin in the pathogenesis of type I diabetes in BB diabetic-prone rats
PNAS,
February 22, 2005;
102(8):
2916 - 2921.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S Graham, P Courtois, W J Malaisse, J Rozing, F W Scott, and A M. I Mowat
Enteropathy precedes type 1 diabetes in the BB rat
Gut,
October 1, 2004;
53(10):
1437 - 1444.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Auricchio, F. Paparo, M. Maglio, A. Franzese, F. Lombardi, G. Valerio, G. Nardone, S. Percopo, L. Greco, and R. Troncone
In Vitro-Deranged Intestinal Immune Response to Gliadin in Type 1 Diabetes
Diabetes,
July 1, 2004;
53(7):
1680 - 1683.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Westerholm-Ormio, O. Vaarala, P. Pihkala, J. Ilonen, and E. Savilahti
Immunologic Activity in the Small Intestinal Mucosa of Pediatric Patients With Type 1 Diabetes
Diabetes,
September 1, 2003;
52(9):
2287 - 2295.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. S. Coulson, P. D. Witterick, Y. Tan, M. J. Hewish, J. N. Mountford, L. C. Harrison, and M. C. Honeyman
Growth of Rotaviruses in Primary Pancreatic Cells
J. Virol.,
August 12, 2002;
76(18):
9537 - 9544.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Collin, K. Kaukinen, M. Valimaki, and J. Salmi
Endocrinological Disorders and Celiac Disease
Endocr. Rev.,
August 1, 2002;
23(4):
464 - 483.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Mikulowska-Mennis, B. Xu, J. M. Berberian, and S. A. Michie
Lymphocyte Migration to Inflamed Lacrimal Glands Is Mediated by Vascular Cell Adhesion Molecule-1/{alpha}4{beta}1 Integrin, Peripheral Node Addressin/L-Selectin, and Lymphocyte Function-Associated Antigen-1 Adhesion Pathways
Am. J. Pathol.,
August 1, 2001;
159(2):
671 - 681.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
J. Schrezenmeir and A. Jagla
Milk and Diabetes
J. Am. Coll. Nutr.,
April 1, 2000;
19(90002):
176S - 190.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Kantele, J. Zivny, M. Hakkinen, C. O. Elson, and J. Mestecky
Differential Homing Commitments of Antigen-Specific T Cells After Oral or Parenteral Immunization in Humans
J. Immunol.,
May 1, 1999;
162(9):
5173 - 5177.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Gessl and W. Waldhäusl
Increased CD69 and Human Leukocyte Antigen-DR Expression on T Lymphocytes in Insulin-Dependent Diabetes Mellitus of Long Standing
J. Clin. Endocrinol. Metab.,
June 1, 1998;
83(6):
2204 - 2209.
[Abstract]
[Full Text]
|
 |
|
Copyright © 1997 by the American Diabetes Association.
|
|
| |
|